News

BRAINTEASER – Halfway point of the project: the midterm workshop

Published on: 13/12/2022

BRAINTEASER – Halfway point of the project: the midterm workshop

As the project has reached the halfway stage, on the 28th February 2023 the Consortium has planned its mid-term workshop.

BRAINTEASER is a data science project that employs AI-based clinical software and mobile apps to support patients with amyotrophic lateral sclerosis and multiple sclerosis, their clinicians and families.

We have developed a prototype app-based solution with the aim of bridging the gap between hospital- and home-care. Through the app, the patients can send data and questions to the clinicians and receive help and suggestions.

We are also integrating wearable app sensor data collected through smart watches and air-quality data collected through wearable sensors. The first, together with the patient input, helps clinicians determine the patient status. The second is useful to study the possible impact of the environment on disease exacerbation.

We have adopted an open-science paradigm. We respect patient data confidentiality and ownership (data are fully anonymous), and, at the same time, challenge the scientific community to compare, discuss and openly publish their systems and solutions, including those developed by BRAINTEASER. 

We have already organised a first open evaluation challenge in September 2022 with the aim of predicting disease prognosis in ALS, and the following is coming in Fall 2023, when we will discuss analogous AI solutions for MS and the possible impact of the environment.

These AI models will be then used to give integrated and augmented information to the clinicians, improving prognostication and intervention timing in routine clinical practice.

As the project has reached the halfway stage, on the 28th February 2023 the Consortium has planned its mid-term workshop.

The organisation of this event comes at the end of the first phase of the project and will serve as a basis to launch the second phase or “pilot phase” that will focus on transforming the current health approach from a reactive to a predictive system focused on risk prediction, patient stratification and prognosis.

The workshop will also serve as a place for reflection on the importance of transformative research, with a view to identifying the opportunities that arise from the National Plan for Recovery and Resilience and the related strategic lines of use of the funds envisaged by the Next Generation EU Programme.

The event, which can be also attended online, will be held in the prestigious location of the University of Padua Botanical Garden, Italy.

The BRAINTEASER Mid Term Workshop Full Programme can be accessed here.


NEWS​

Related News

New Round Tables announced to drive progress on EHDS and health AI

3 Jul 2025

The European Accessibility Act Is Here. Are You Ready?

2 Jul 2025
Why inclusive design is no longer optional – and how Big Motive can help you lead the way.

DTH-Lab Director: The G7 must act now to address the digital health transformation

2 Jul 2025
As digital platforms increasingly shape health systems and information flows, the G7 must lead in setting global standards to ensure safety, equity an...

InnoHSupport Open Calls

1 Jul 2025
Welcome to the InnoHSupport Open Calls!

Transformative Health Instrument Call 2025

1 Jul 2025
Apply to the Transformative Health Instrument (THI) Call 2025 if you are a growing and innovative healthcare start-up working on solutions that have s...

Longitude Prize on ALS

1 Jul 2025
The £7.5 million (~$10 million) Longitude Prize on ALS incentivises the use of AI-based approaches to transform drug discovery for amyotrophic lateral...

Become a member

Join ECHAlliance to amplify your organisation’s message, grow your networks, connect with innovators and collaborate globally.
 
First name *
Last Name *
Email Address *
Country *
Position *
First name *
Last Name *
Email Address *
Country *
Position *